Accuray Inc
NASDAQ:ARAY

Watchlist Manager
Accuray Inc Logo
Accuray Inc
NASDAQ:ARAY
Watchlist
Price: 0.3922 USD -8.9% Market Closed
Market Cap: $46.6m

Accuray Inc
Total Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Accuray Inc
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Accuray Inc
NASDAQ:ARAY
Total Equity
$53.4m
CAGR 3-Years
1%
CAGR 5-Years
-7%
CAGR 10-Years
-1%
Boston Scientific Corp
NYSE:BSX
Total Equity
$24.2B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
14%
Edwards Lifesciences Corp
NYSE:EW
Total Equity
$10.3B
CAGR 3-Years
21%
CAGR 5-Years
18%
CAGR 10-Years
15%
Stryker Corp
NYSE:SYK
Total Equity
$22.4B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
10%
Abbott Laboratories
NYSE:ABT
Total Equity
$52.1B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
9%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Equity
$17.8B
CAGR 3-Years
17%
CAGR 5-Years
13%
CAGR 10-Years
15%
No Stocks Found

Accuray Inc
Glance View

Market Cap
46.6m USD
Industry
Health Care

Accuray, Inc. is a radiation oncology company. The company is headquartered in Sunnyvale, California and currently employs 995 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The firm's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

ARAY Intrinsic Value
Not Available

See Also

What is Accuray Inc's Total Equity?
Total Equity
53.4m USD

Based on the financial report for Dec 31, 2025, Accuray Inc's Total Equity amounts to 53.4m USD.

What is Accuray Inc's Total Equity growth rate?
Total Equity CAGR 10Y
-1%

Over the last year, the Total Equity growth was 12%. The average annual Total Equity growth rates for Accuray Inc have been 1% over the past three years , -7% over the past five years , and -1% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett